Regulation of antitumour CD8 T-cell immunity and checkpoint blockade immunotherapy by Neuropilin-1

Marine Leclerc(Université Paris-Sud), Fathia Mami‐Chouaib(Université Paris-Sud)
Nature Communications
July 26, 2019
10.1038/s41467-019-11280-z
Cited by 144

Related Papers

Recent Advances in Targeting CD8 T-Cell Immunity for More Effective Cancer Immunotherapy
|Frontiers in Immunology|2018|513
Resident memory T cells, critical components in tumor immunology
|Journal for ImmunoTherapy of Cancer|2018|333
The Emerging Role of CD8+ Tissue Resident Memory T (TRM) Cells in Antitumor Immunity: A Unique Functional Contribution of the CD103 Integrin
|Frontiers in Immunology|2018|161